UK Medicines Regulator A 'Serious Risk' to Patient Safety
Wednesday, Feb 21 2024
Most of the so-called regulatory agencies in Western nations are captured by the money power and serve corporate interests, those of big-pharma. This includes the CDC, FDA as well as the MHRA in the UK, and similarly, world organisations such as the WHO, which are captured by Malthusians such as Bill Gates, the Chinese Communists and major Western powers. This organisation is used for a range of objectives. Agencies such as the CDC, FDA and MHRA also exist to prevent real cures from reaching people, to financially and legally destroy those who bring cheap, effective, natural cures and treatments.
Here is a recent article published in Medscape regarding the UK "regulator" MHRA.
The All-Party Parliamentary Group (APPG) on pandemic response and recovery has raised "serious patient safety concerns" about the Medicines and Healthcare products Regulatory Agency (MHRA), along with other aspects of a system that, "far from protecting patients, continues to put them at serious risk".
In a letter to Health Secretary Steve Brine, APPG co-chairs Esther McVey and Graham Stringer, with 26 cosignatories, highlighted the Independent Medicines and Medical Devices Safety (IMMDS) investigation of Primodos, sodium valproate, and pelvic mesh scandals, which found the response of the healthcare system was not sufficiently robust, speedy, or appropriate, causing some patients to suffer life-changing or fatal, avoidable harm. MHRA at "the Tip of a Sizeable Iceberg of Failure"
Subsequent evidence "leads us to believe that serious patient safety concerns persist beyond even the findings of the IMMDS review", the APPG signatories wrote. "The MHRA is at the heart of these far wider endemic failings," and "those cited in this letter merely represent the tip of a sizeable iceberg of failure."
Medscape News UK has reported increasing concern worldwide about the degree to which medicines regulators are captured by the drug industry. A 2022 BMJ investigation found serious conflicts of interest potentially influencing health policy and approval decisions. Regulatory agency members and expert advisers had financial interests in products being licensed, including several experts on COVID-19 vaccine advisory committees with financial ties to vaccine manufacturers that regulators did not always disclose.
Notorious "revolving door" arrangements mean many officials move between regulatory agencies and the companies they regulate. For example, a former MHRA chief executive arrived from SmithKline Beecham and left to serve on the board of a biotech company and advise the Gates Foundation, which has major interests in vaccines and partly funds the MHRA.
"A Prime Example of Institutional Corruption"
One expert cited in the BMJ described the situation as "a prime example of institutional corruption". In 2020-21, 98.5% of applications for new medicines approvals yielded positive decisions.
The APPG drew attention to MHRA chief executive Dame June Raine's statement in March 2022 that the agency had transitioned “from watchdog to enabler”.
"Enabler of what?" the letter asked, saying the statement "does little to quell suspicions of conflicts, and the implications for patient safety cannot be overlooked".
Medscape UK — 19 February 2024
Source: Medscape UK
